Back to Search
Start Over
Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point
- Source :
- Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 16(11)
- Publication Year :
- 2007
-
Abstract
- The stated goal for an investment in cancer research is the eradication of cancer. But this is just talk. A world with no cancer is a noble goal but the problem becomes where to start. In other words, how to put ideas into action and move forward from rhetoric. The task is enormous, but one solution
- Subjects :
- Oncology
medicine.medical_specialty
Antineoplastic Agents, Hormonal
Epidemiology
media_common.quotation_subject
Breast Neoplasms
Task (project management)
Breast cancer
Internal medicine
medicine
Anticarcinogenic Agents
Humans
Raloxifene
media_common
Clinical Trials as Topic
Point (typography)
business.industry
Cancer
Public relations
medicine.disease
Postmenopause
Tamoxifen
Action (philosophy)
Raloxifene Hydrochloride
Rhetoric
Female
business
medicine.drug
Subjects
Details
- ISSN :
- 10559965
- Volume :
- 16
- Issue :
- 11
- Database :
- OpenAIRE
- Journal :
- Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
- Accession number :
- edsair.doi.dedup.....63498c96e28967233c5519732ae67b74